However, these are very much up in the air after reporting have been surfacing saying that the US president may not enact the triple-digit pharma tariffs after all.5 Rather the tariffs could potentially use as negotiating tactic with pharma companies while they work out deals with the government to lower drug costs.
Fast facts: Trump’s latest tariff announcement
- New tariff threat: 10% hike on all Canadian imports following a controversial Reagan-themed ad.
- Current rates: Tariffs on Canada already at 35% since August 2025.
- Reagan Foundation response: Confirmed no authorization was given for the ad’s edited remarks.
- Pharma angle: Trump has threatened 100% tariffs on branded drugs unless production moves to the U.S.
- Legal context: An August court ruling deemed many tariffs “null and void”; appeals are ongoing.
Legal challenges and policy outlook
This is all taking place amid an August ruling by a lower court declaring that a majority of Trump’s tariffs are null and void.
The appeals court decision arises from two separate cases: one filed by five small import businesses—including a New York wine and spirits distributor and a Pennsylvania sport fishing retailer—and another brought by 12 states (Arizona, Colorado, Connecticut, Delaware, Illinois, Maine, Minnesota, Nevada, New Mexico, New York, Oregon, and Vermont), the majority of which are led by Democratic governors.
Trump invoked IEEPA—a 1977 federal law that gives him the authority to control international commerce and implement economic sanctions during declared national emergencies caused by extraordinary threats to national security, foreign policy, or the economy arising outside the United States—in order to enact these tariffs on trading partners that date back to early February.
The hearing is specifically referencing when Trump decided to impose 25% tariffs on Mexican and Canadian imports—along with 10% on goods coming from China—to encourage these nations to act on limiting illegal immigrants and fentanyl from entering the United States.
The president has been a supporter of enacting tariffs on manufacturers in order to encourage reshoring of these processes back to the United States, and now, oral arguments are expecting by early November.
References
1. Schiefelbein M. Trump Threatens Canada With 10% Extra Import Tax for Not Pulling Down Anti-Tariffs Ad Sooner. AP. October 25, 2025. Accessed October 27, 2025. https://apnews.com/article/trump-canada-tariffs-3cbc1cbf9ed53a10b442fd55dae1e0a3
2. Lopez E. Trump to Raise Canada Tariffs by 10%. Supply Chain Dive. October 25, 2025. Accessed October 27, 2025. https://www.supplychaindive.com/news/trump-raises-canada-tariffs-10-percent/803811/
3. President Trump’s Truth Social post. https://truthsocial.com/@realDonaldTrump/posts/115436697060819133
4. Saraceno N. Trump Announces 100% Tariff on Branded Drugs Unless Pharma Builds US Plants. Pharmaceutical Commerce. October 25, 2025. Accessed October 27, 2025. https://www.pharmaceuticalcommerce.com/view/trump-100-percent-tariff-branded-drugs
5. Hollan M. Trump Pauses Plans to Impose 100% Tariffs on Pharma: Report. Pharmaceutical Executive. October 25, 2025. Accessed October 27, 2025. https://www.pharmexec.com/view/trump-pauses-plans-impose-100-tariffs-report
6. Saraceno N. Trump Pushes Supreme Court to Save Tariffs After Appeals Court Ruling Limits Presidential Power. Pharmaceutical Commerce. September 4, 2025. Accessed October 27, 2025. https://www.pharmaceuticalcommerce.com/view/trump-pushes-supreme-court-save-tariffs-appeals-court-ruling